Status: current, Primitive. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3758396016 | Nilotinib hydrochloride (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3758397013 | Nilotinib hydrochloride | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Nilotinib hydrochloride | Has disposition | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Nilotinib hydrochloride | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Nilotinib hydrochloride | Is modification of | Nilotinib | true | Inferred relationship | Some | ||
| Nilotinib hydrochloride | Is a | Aminopyrimidine | true | Inferred relationship | Some | ||
| Nilotinib hydrochloride | Is a | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Nilotinib hydrochloride | Is a | Imidazole | true | Inferred relationship | Some | ||
| Nilotinib hydrochloride | Is a | Antineoplastic agent | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Nilotinib hydrochloride monohydrate | Is modification of | True | Nilotinib hydrochloride | Inferred relationship | Some | |
| Nilotinib (as nilotinib hydrochloride) 200 mg oral capsule | Has precise active ingredient | True | Nilotinib hydrochloride | Inferred relationship | Some | 1 |
| Nilotinib (as nilotinib hydrochloride) 150 mg oral capsule | Has precise active ingredient | True | Nilotinib hydrochloride | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR